Literature DB >> 28452184

Prognostic survival value of retropharyngeal lymph node involvement in sinonasal tumors: A retrospective, descriptive, and exploratory study.

Katharina Gangl1, Stefan Nemec2, Gabriela Altorjai3, Johannes Pammer4, Matthaeus Ch Grasl1, Boban M Erovic1.   

Abstract

BACKGROUND: Sinonasal carcinomas are rare. The purpose of this study was for us to present our assessment of the effects of retropharyngeal lymph node involvement at diagnosis on patient outcomes.
METHODS: Retropharyngeal lymph node involvement in 36 patients with sinonasal carcinoma was determined by radiology at initial presentation. Clinical outcome, in particular, overall survival (OS) and locoregional control, was assessed by Kaplan-Meier analysis and log-rank testing.
RESULTS: Retropharyngeal lymph node involvement was associated with statistically significant decreased OS (P = .0066) in the patient collective. In the squamous cell carcinoma (SCC) subgroup (n = 23), decreased OS (P = .0046) and worse locoregional control (P = .0065) were observed. In these patients, decreased OS (P = .0423) and worse locoregional control (P = .0315) were also seen in the advanced tumor subgroup.
CONCLUSION: Retropharyngeal lymph node involvement at diagnosis is a significant prognostic factor for decreased OS and locoregional control in sinonasal carcinoma.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  metastasis; prognostic factor; retropharyngeal lymph node; sinonasal carcinoma; survival analysis

Mesh:

Year:  2017        PMID: 28452184     DOI: 10.1002/hed.24782

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  1 in total

1.  Lymph Node Metastasis Spread Patterns and the Effectiveness of Prophylactic Neck Irradiation in Sinonasal Squamous Cell Carcinoma (SNSCC).

Authors:  Qian Liu; Yuan Qu; Kai Wang; Runye Wu; Ye Zhang; Xiaodong Huang; Jianghu Zhang; Xuesong Chen; Jingbo Wang; Jianping Xiao; Junlin Yi; Guozhen Xu; Jingwei Luo
Journal:  Front Oncol       Date:  2022-05-30       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.